37517-26-3CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1KTOYYUONFQWSMW-UHFFFAOYSA-NPipotiazine palmitate is a member of phenothiazines.
37517-26-3Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P332+P317, P333+P317, P362+P364, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
DescriptionPipotiazine palmitate, a long-acting antipsychotic generally administered as an injection and not available as an oral medication, was withdrawn globally in March 2015 in favour of other antipsychotic medications due to a shortage of its active ingredient.
UsesAntipsychotic.
UsesPipotiazine palmitate is an antipsychotic medication used for the maintenance treatment of patients with chronic non agitated schizophrenia.
DefinitionChEBI: Pipotiazine palmitate is a member of phenothiazines.
Loading…
Loading…
No reaction records under the current filter.
Loading…
DTXSID5048970CHEMBL2106439CHEBI:135769